Related Experiment Video
Updated: Jan 27, 2026

Author Spotlight: Advancing Tissue Regeneration and Disease Modeling with Dental Pulp Stem Cells
Published on: May 5, 2023
Portland cement as pulp dressing agent in pulpotomy treatment of primary molars: a 12-month clinical study
M Maroto1, S Barreiro1, E Barbería1
1Department of Stomatology IV, Faculty of Dentistry, Complutense University of Madrid, Madrid, Spain.
Aim:
Pulpotomy is the most frequent endodontic treatment performed on primary teeth. Different pulpotomy procedures and materials have been studied during the last years and recently interest has been focused on the use of Portland Cement (PC) as an alternative to these materials including Mineral Trioxide Aggregate (MTA), but still few clinical studies have been carried out. The aim of this study was to analyse the clinical and radiographic response to the use of Portland cement (PC) in primary molars pulpotomies through a clinical study in paediatric patients.
Materials And Methods:
Eleven carious primary mandibular molars of children aged 3-9 years old were treated by a conventional pulpotomy technique using PC. The teeth were restored with stainless steel crown. Clinical and radiographic follow-up was performed 6 and 12 months after the treatment.
Results:
All the treated molars were clinically and radiographically successful at all the follow-up appointments as no pathological findings were observed in any molar. Reparative dentin formation was observed in 100% of the treated molars.
Conclusions:
PC could be considered a reasonable alternative to the use of MTA in pulpotomy treatments in primary molars, although more long-term clinical studies are needed to confirm these results.
Related Concept Videos
Portland Cement
Molar Mass
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Hydration of Cement
Soundness of Cement
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

